title: [Immunoblastic lymphadenopathy-like T cell lymphoma with high level of serum interleukin-2 and various allergic reactions].
authors.forename: Masayuki
authors.initials: M
authors.lastname: Tsujisaki
authors.forename: Seiya
authors.initials: S
authors.lastname: Nakahara
authors.forename: Yoshie
authors.initials: Y
authors.lastname: Kazama
authors.forename: Haruo
authors.initials: H
authors.lastname: Shimizu
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Yoshimoto
authors.forename: Tohru
authors.initials: T
authors.lastname: Takahashi
authors.forename: Yoshimasa
authors.initials: Y
authors.lastname: Okada
authors.forename: Shigeru
authors.initials: S
authors.lastname: Sasaki
authors.forename: Kohzoh
authors.initials: K
authors.lastname: Imai
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy / Q000209:etiology; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D006942:Hypergammaglobulinemia / Q000188:drug therapy / Q000209:etiology; D007119:Immunoblastic Lymphadenopathy / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D007073:Immunoglobulin E; D007376:Interleukin-2 / Q000097:blood*; D016399:Lymphoma, T-Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D007376:Interleukin-2; D007073:Immunoglobulin E; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone